tetano
Editor, Senior Moderator
Clin Case Rep
. 2023 Nov 14;11(11):e8181.
doi: 10.1002/ccr3.8181. eCollection 2023 Nov. Long-term follow-up of a young male who developed acute macular neuroretinopathy following COVID-19 vaccination
Shunsuke Ikema[SUP] 1 [/SUP], Gen Miura[SUP] 1 [/SUP], Daisuke Shimizu[SUP] 1 [/SUP], Takayuki Baba[SUP] 1 [/SUP]
Affiliations
This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID-19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no recurrence was observed for 1 year.
Keywords: COVID‐19; acute macular neuroretinopathy; coronavirus; vaccine.
. 2023 Nov 14;11(11):e8181.
doi: 10.1002/ccr3.8181. eCollection 2023 Nov. Long-term follow-up of a young male who developed acute macular neuroretinopathy following COVID-19 vaccination
Shunsuke Ikema[SUP] 1 [/SUP], Gen Miura[SUP] 1 [/SUP], Daisuke Shimizu[SUP] 1 [/SUP], Takayuki Baba[SUP] 1 [/SUP]
Affiliations
- PMID: 38028086
- PMCID: PMC10645608
- DOI: 10.1002/ccr3.8181
This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID-19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no recurrence was observed for 1 year.
Keywords: COVID‐19; acute macular neuroretinopathy; coronavirus; vaccine.